Background: Cardiovascular disease remains the most common cause of morbidity and mortality in Type 2 Diabetes Mellitus. Insulin Resistance and Dyslipidemia are the important factors contributing to cardiovascular risk in Diabetes. Adiponectin is an adipocytokine involved in the regulation of glucose and lipid metabolism. In the present study we studied the association of Plasma Adiponectin with Insulin Resistance and Lipid prole parameters in Type 2 Diabetes.Materials and Methods: The study included 100 Type 2 Diabetic Subjects and 100 age-matched healthy individuals with no history of Diabetes. The Anthropometric measurements, Fasting and Post prandial plasma glucose, Fasting insulin, Plasma Adiponectin and Lipid prole were measured in these subjects. HOMA- IR formula was used to calculate Insulin Resistance. Results: Fasting and Post prandial plasma glucose, Insulin and HOMA-IR were increased in Type 2 Diabetic Subjects when compared to controls. Plasma Adiponectin was signicantly reduced in Type 2 Diabetic Subjects compared to controls. In Type 2 Diabetic Subjects, Plasma Adiponectin was found signicantly inversely correlated with insulin resistance (r=-0.58, p<0.01), Total cholesterol (r=-0.51, p<0.01), Triglycerides (r=-0.44, p<0.01) and LDL-C levels (r=-0.56, p<0.01). Asignicant Positive correlation was also observed between Plasma Adiponectin and HDL-C level (r=0.37, p<0.01) in Type 2 Diabetic Subjects. Conclusion:Hypoadiponectinemia in Type 2 Diabetes is associated with Insulin Resistance and Dyslipidemia and plays a key role in the development of cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Kanakasabai et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: